Authors:
Bjorkstrand, B
Svensson, H
Goldschmidt, H
Ljungman, P
Apperley, J
Mandelli, F
Marcus, R
Boogaerts, M
Alegre, A
Remes, K
Cornelissen, JJ
Blade, J
Lenhoff, S
Iriondo, A
Carlson, K
Volin, L
Littlewood, T
Goldstone, AH
San Miguel, J
Schattenberg, A
Gahrton, G
Citation: B. Bjorkstrand et al., Alpha-interferon maintenance treatment is associated with improved survival after high-dose treatment and autologous stem cell transplantation in patients with multiple myeloma: a retrospective registry study from the European Group for Blood and Marrow Transplantation (EBMT), BONE MAR TR, 27(5), 2001, pp. 511-515
Authors:
van Esser, JWJ
Niesters, HGM
Thijsen, SFT
Meijer, E
Osterhaus, ADME
Wolthers, KC
Boucher, CAB
Gratama, JW
Budel, LM
van der Holt, B
van Loon, AM
Lowenberg, B
Verdonck, LF
Cornelissen, JJ
Citation: Jwj. Van Esser et al., Molecular quantification of viral load in plasma allows for fast and accurate prediction of response to therapy of Epstein-Barr virus-associated lymphoproliferative disease after allogeneic stem cell transplantation, BR J HAEM, 113(3), 2001, pp. 814-821
Authors:
Gratama, JW
van Esser, JWJ
Lamers, CHJ
Toumay, C
Lowenberg, B
Bolhuis, RLH
Cornelissen, JJ
Citation: Jw. Gratama et al., Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8(+) T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection, BLOOD, 98(5), 2001, pp. 1358-1364
Authors:
van Esser, JWJ
van der Holt, B
Meijer, E
Niesters, HGM
Trenschel, R
Thijsen, SFT
van Loon, AM
Frassoni, F
Bacigalupo, A
Schaefer, UW
Osterhaus, ADME
Gratama, JW
Lowenberg, B
Verdonck, LF
Cornelissen, JJ
Citation: Jwj. Van Esser et al., Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneicstem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell-depleted SCT, BLOOD, 98(4), 2001, pp. 972-978
Authors:
Lokhorst, HM
Schattenberg, A
Cornelissen, JJ
van Oers, MHJ
Fibbe, W
Russell, I
Van der Donk, NWCJ
Verdonck, LF
Citation: Hm. Lokhorst et al., Donor lymphocyte infusions for relapsed multiple myeloma after allogeneic stem-cell transplantation: Predictive factors for response and long-term outcome, J CL ONCOL, 18(16), 2000, pp. 3031-3037
Authors:
Janssen, JJWM
van Rijn, RS
van der Holt, B
Schuurhuis, GJ
Vellenga, E
Verhoef, GEG
Ossenkoppele, GJ
van den Berg, E
Hagemeijer, A
Slater, R
Nieuwint, AWM
Cornelissen, JJ
Citation: Jjwm. Janssen et al., Mobilisation of haemopoietic progenitors in CML: a second course of intensive chemotherapy does not improve Ph-negativity in stem cell harvests, BONE MAR TR, 25(11), 2000, pp. 1147-1155
Authors:
van Hennik, PB
Breems, DA
Kusadasi, N
Slaper-Cortenbach, ICM
van den Berg, H
van der Lelie, HJ
Schipperus, MR
Cornelissen, JJ
Ploemacher, RE
Citation: Pb. Van Hennik et al., Stroma-supported progenitor production as a prognostic tool for graft failure following autologous stem cell transplantation, BR J HAEM, 111(2), 2000, pp. 674-684
Authors:
Broers, AEC
van der Holt, R
van Esser, JWJ
Gratama, JW
Henzen-Logmans, S
Kuenen-Boumeester, V
Lowenberg, B
Cornelissen, JJ
Citation: Aec. Broers et al., Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneicT-cell-depleted stem cell transplantation, BLOOD, 95(7), 2000, pp. 2240-2245
Authors:
Champlin, RE
Schmitz, N
Horowitz, MM
Chapuis, B
Chopra, R
Cornelissen, JJ
Gale, RP
Goldman, JM
Loberiza, FR
Hertenstein, B
Klein, JP
Montserrat, E
Zhang, MJ
Ringden, O
Tomany, SC
Rowlings, PA
Van Hoef, MEHM
Gratwohl, A
Citation: Re. Champlin et al., Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation, BLOOD, 95(12), 2000, pp. 3702-3709
Authors:
Verstegen, MMA
Cornelissen, JJ
Terpstra, W
Wagemaker, G
Wognum, AW
Citation: Mma. Verstegen et al., Multilineage outgrowth of both malignant and normal hemopoietic progenitorcells from individual chronic myeloid leukemia patients in immunodeficientmice, LEUKEMIA, 13(4), 1999, pp. 618-628
Authors:
Lokhorst, HM
Sonneveld, P
Cornelissen, JJ
Joosten, P
Kooy, MV
Meinema, J
Nieuwenhuis, HK
van Oers, MHJ
Richel, DJ
Segeren, CN
Veth, G
Verdonck, LF
Wijermans, PW
Citation: Hm. Lokhorst et al., Induction therapy with vincristine, adriamycin, dexamethasone (VAD) and intermediate-dose melphalan (IDM) followed by autologous or allogeneic stem cell transplantation in newly diagnosed multiple myeloma, BONE MAR TR, 23(4), 1999, pp. 317-322
Authors:
Gadisseur, APA
Gratama, JW
Lamers, C
van Esser, JWJ
Bolhuis, RLH
Cornelissen, JJ
Citation: Apa. Gadisseur et al., Expression of T cell activation antigen CD134 (OX40) has no predictive value for the occurrence or response to therapy of acute graft-versus-host disease in partial T cell-depleted bone marrow transplantation, BONE MAR TR, 23(10), 1999, pp. 1013-1017
Authors:
Cornelissen, JJ
Fibbe, WE
Schattenberg, AVMB
Petersen, EJ
Willemze, R
de Witte, TJM
Lijwenberg, B
Verdonck, LF
Van der Biezen, A
Brand, R
Citation: Jj. Cornelissen et al., A retrospective Dutch study comparing T-cell depleted allogeneic blood stem cell transplantation vs T-cell depleted allogeneic bone marrow transplantation, TRANSFUS SC, 19(3), 1998, pp. 196-197